AMGEN DEAL: Biotech pioneer Amgen will pay $415 million for Iceland’s deCODE Genetics, a leader in using genetic information to find disease risk factors and treatment targets.
THE RATIONALE: Amgen, the world’s largest biotech company by revenue, wants to use deCODE’s huge database of genetic and medical information on Iceland’s population to find targets for diseases linked to genes.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.